Engineering a Brain Cancer Chip for High-throughput Drug Screening

Area of Science:

• Biomedical Engineering
• Oncology
• Materials Science

Background:

• Glioblastoma multiforme (GBM) is an aggressive brain cancer.
• Conventional 2D cell cultures poorly mimic native brain tumor physiology.
• Effective drug screening is crucial for GBM treatment development.

Purpose of the Study:

• To develop a novel three-dimensional (3D) brain cancer chip for enhanced drug screening.
• To create a reproducible and scalable platform for glioblastoma research.
• To assess the efficacy of combinatorial drug treatments on a 3D GBM model.

Main Methods:

• Fabrication of a 3D brain cancer chip using photo-polymerizable poly(ethylene) glycol diacrylate (PEGDA) hydrogel.
• Culture of glioblastoma cells (U87) to form 3D brain cancer tissues (spheroids) on the chip.
• Application of combinatorial treatment with Pitavastatin and Irinotecan for drug response testing.

Main Results:

• The chip facilitates rapid, high-throughput formation of glioblastoma spheroids.
• It enables multiple simultaneous drug administrations and massive parallel drug response testing.
• The 3D chip provides a more physiologically relevant model for drug screening compared to 2D cultures.

Conclusions:

• The novel 3D brain cancer chip is a powerful, reproducible platform for high-throughput drug screening.
• This technology has potential for evaluating combinatorial therapies and prolonged drug release.
• The chip shows commercial promise for 3D cell culture and micro-scale tissue engineering applications in oncology.